Rhesus monkeys were completely protected from Ebola virus when treated three days after infection with a compound that blocks the virus's ability to replicate. These encouraging preclinical results suggest the compound, known ...
Mar 3, 2016
0
47
Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and colleagues have discovered that a single monoclonal antibody—a protein that attacks viruses—isolated ...
Feb 25, 2016
0
47
As world leaders grapple with containing the Zika virus, the Ebola epidemic in West Africa provides valuable lessons for how to respond to infectious disease epidemics, according to a policy report published by researchers ...
Feb 18, 2016
0
44
A research team that included scientists from The Scripps Research Institute (TSRI) has identified a new group of powerful antibodies to fight Ebola virus.
Feb 18, 2016
0
24
Researchers at Albert Einstein College of Medicine and the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) have engineered the first antibodies that can potently neutralize the two deadliest strains ...
Jan 13, 2016
0
844
Scientists have performed the first comprehensive genomic analysis of Ebola virus sequences from Liberia, one of three countries widely affected by the devastating outbreak that began in 2013 in Western Africa. Their work, ...
Dec 9, 2015
0
35
A team of scientists at Royal Holloway, led by Professor George Dickson, and as part of the UK HIV Vaccine Consortium, led by Professor Jonathon Weber at Imperial College London, has developed a prototype HIV vaccine vector ...
Nov 16, 2015
0
201
Using a novel statistical model, a research team led by Columbia University's Mailman School of Public Health mapped the spread of the 2014-2015 Ebola outbreak in Sierra Leone, providing the most detailed picture to date ...
Nov 10, 2015
0
62
The Ebola virus may persist in some men's semen for nine months after they were initially infected, far longer than previously thought, according to preliminary research out Wednesday.
Oct 14, 2015
0
159
Genetic mutations called "escape variants" in the deadly Ebola virus appear to block the ability of antibody-based treatments to ward off infection, according to a team of U.S. Army scientists and collaborators. Their findings, ...
Sep 11, 2015
0
236
